- Title
- Preliminary study: Treatment with intramuscular interferon beta-1a results in increased levels of IL-12Rβ2+ and decreased levels of IL23R+ CD4+ T - Lymphocytes in multiple sclerosis
- Creators
- Jennifer M Kress-Bennett - Center for Genomic Sciences, Allegheny-Singer Research Institute, 320 East North Avenue, Pittsburgh, PA 15212, USAGarth D Ehrlich - Center for Genomic Sciences, Allegheny-Singer Research Institute, 320 East North Avenue, Pittsburgh, PA 15212, USAAshley Bruno - Department of Neurology, Allegheny General Hospital, 320 East North Avenue, East Wing, Pittsburgh PA, 15212; USAJ Christopher Post - Center for Genomic Sciences, Allegheny-Singer Research Institute, 320 East North Avenue, Pittsburgh, PA 15212, USAFen Z Hu - Center for Genomic Sciences, Allegheny-Singer Research Institute, 320 East North Avenue, Pittsburgh, PA 15212, USAThomas F Scott - Department of Neurology, Allegheny General Hospital, 320 East North Avenue, East Wing, Pittsburgh PA, 15212; USA
- Publication Details
- BMC neurology, v 11(1), pp 155-155
- Publisher
- BioMed Central
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Microbiology and Immunology
- Web of Science ID
- WOS:000301152900001
- Scopus ID
- 2-s2.0-83655203230
- Other Identifier
- 991014877787904721
Journal article
Preliminary study: Treatment with intramuscular interferon beta-1a results in increased levels of IL-12Rβ2+ and decreased levels of IL23R+ CD4+ T - Lymphocytes in multiple sclerosis
BMC neurology, v 11(1), pp 155-155
19 Dec 2011
PMID: 22182694
Featured in Collection : UN Sustainable Development Goals @ Drexel
Metrics
Details
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Clinical Neurology